ArticleImmunologic research2025
Somatic mosaicism of CYBB causing atypical CGD with inflammatory symptoms.
Article in Immunologic research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Chronic granulomatous disease (CGD) is a rare inborn error of immunity (IEI) characterized by a defective respiratory burst in phagocytes and defective clearance of phagocytosed microorganisms. CGD is caused by a defect of the enzyme NADPH oxidase, resulting in severe and life-threatening infections in affected children. The genetically heterogeneous X-linked recessive form of CGD (XL-CGD) is caused by mutations in the CYBB gene. XL-CGD is typically diagnosed early in life, usually before the age of 3 years. The present report describes a boy aged 9 years and 11 months who presented with oral ulcers, cutaneous lesions, and uveitis. Whole-exome sequencing (WES) detected a mosaic, pathogenic nonsense variant (p.Arg157X) in CYBB. This pathogenic variant was present in ~ 60% of peripheral leukocytes in this patient, a percentage sufficient to result in defective production of reactive oxygen species (ROS), but not life-threatening infections, including BCG lymphadenitis following BCG vaccination. This study describes a somatic mosaicism mutation in the CYBB gene that can cause atypical CGD with inflammatory symptoms.
Indexed as
Identifiers
41410980What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.